Preoperative Nutritional Risk Index Predicts Recurrence of Oligometastatic Prostate Cancer in Patients Undergoing Cytoreductive Radical Prostatectomy

References

• Hellman S, Weichselbaum RR. Oligometastases. J Clin Oncol. 1995;13(1):8–10. doi:10.1200/JCO.1995.13.1.8
   PubMed Web of Science ®Google Scholar
• Tosoian JJ, Gorin MA, Ross AE, et al. Oligometastatic prostate cancer: definitions, clinical outcomes, and treatment considerations. Nat Rev Urol. 2017;14:15–25.
   PubMed Web of Science ®Google Scholar
• Singh D, Yi WS, Brasacchio RA, et al. Is there a favorable subset of patients with prostate cancer who develop oligometastases? Int J Radiat Oncol Biol Phys. 2004;58:3–10.
   PubMed Web of Science ®Google Scholar
• Ost P, Decaestecker K, Lambert B, Fonteyne V, Delrue L, Lumen N, Ameye F, De Meerleer G. Prognostic factors influencing prostate cancer-specific survival in non-castrate patients with metastatic prostate cancer. Prostate. 2014;74(3):297–305. doi:10.1002/pros.22750
   PubMed Web of Science ®Google Scholar
• Halabi S, Kelly WK, Ma H, Zhou H, Solomon NC, Fizazi K, Tangen CM, Rosenthal M, Petrylak DP, Hussain M, et al. Meta-analysis evaluating the impact of site of metastasis on overall survival in men with castration-resistant prostate cancer. J Clin Oncol. 2016;34(14):1652–1659. doi:10.1200/JCO.2015.65.7270
   PubMed Web of Science ®Google Scholar
• Halabi S, Lin C-Y, Kelly WK, Fizazi KS, Moul JW, Kaplan EB, Morris MJ, Small EJ. Updated prognostic model for predicting overall survival in first-line chemotherapy for patients with metastatic castration-resistant prostate cancer. J Clin Oncol. 2014;32(7):671–677. doi:10.1200/JCO.2013.52.3696
   PubMed Web of Science ®Google Scholar
• Gandaglia G, Karakiewicz PI, Briganti A, et al. Impact of the site of metastases on survival in patients with metastatic prostate cancer. Eur Urol. 2015;68:325–334.
   PubMed Web of Science ®Google Scholar
• Ost P, Reynders D, Decaestecker K, Fonteyne V, Lumen N, De Bruycker A, Lambert B, Delrue L, Bultijnck R, Claeys T, et al. Surveillance or metastasis-directed therapy for oligometastatic prostate cancer recurrence: a prospective, randomized, multicenter phase II trial. J Clin Oncol. 2018;36(5):446–453. doi:10.1200/JCO.2017.75.4853
   PubMed Web of Science ®Google Scholar
• Guo Y, Shi D, Zhang J, et al. The hemoglobin, albumin, lymphocyte, and platelet (HALP) score is a novel significant prognostic factor for patients with metastatic prostate cancer undergoing cytoreductive radical prostatectomy. J Cancer. 2019;10:81–91.
   PubMed Web of Science ®Google Scholar
• Artigas C, Flamen P, Charlier F, et al. Ga-PSMA PET/CT-based metastasis-directed radiotherapy for oligometastatic prostate cancer recurrence after radical prostatectomy. World J Urol. 2019; 171–179.
   Web of Science ®Google Scholar
• McMillan DC. Systemic inflammation, nutritional status and survival in patients with cancer. Curr Opin Clin Nutr Metab Care. 2009;12:223–226.
   PubMed Web of Science ®Google Scholar
• Rock CL, Doyle C, Demark-Wahnefried W, et al. Nutrition and physical activity guidelines for cancer survivors. CA Cancer J Clin. 2012;62:243–274.
   PubMed Web of Science ®Google Scholar
• Liu X, Meng QH, Ye Y, et al. Prognostic significance of pretreatment serum levels of albumin, LDH and total bilirubin in patients with non-metastatic breast cancer. Carcinogenesis. 2015;36:243–248.
   PubMed Web of Science ®Google Scholar
• Cao Y, Ma J. Body mass index, prostate cancer-specific mortality, and biochemical recurrence: a systematic review and meta-analysis. Cancer Prev Res. 2011;4(4):486–501. doi:10.1158/1940-6207.CAPR-10-0229
   PubMed Web of Science ®Google Scholar
• Fan L, Wang X, Chi C. et al. Prognostic nutritional index predicts initial response to treatment and prognosis in metastatic castration-resistant prostate cancer patients treated with abiraterone. Prostate. 2017;77:1233–1241.
   PubMed Web of Science ®Google Scholar
• Veterans Affairs Total Parenteral Nutrition Cooperative Study Group. Perioperative total parenteral nutrition in surgical patients. New England J Med. 1991;325:525–532.
   PubMed Web of Science ®Google Scholar
• Ramos R, Ernest N, Inma P, et al. Preoperative nutritional status assessment predicts postoperative outcomes in patients with surgically resected non-small cell lung cancer. Eur J Surg Oncol. 2018;44:1419–1424.
   PubMed Web of Science ®Google Scholar
• Kim CY, Kim SY, Song JH, et al. Usefulness of the preoperative prognostic nutritional index score as a predictor of the outcomes of lung transplantation: a single-institution experience. Clin Nutr. 2018; 2423–2429.
   PubMed Web of Science ®Google Scholar
• Sasahara M, Kanda M, Ito S, et al. The preoperative prognostic nutritional index predicts short-term and long-term outcomes of patients with stage II/III gastric cancer: analysis of a multi-institution dataset. Diges Surg. 2019;37:1–10.
   PubMed Web of Science ®Google Scholar
• Camp RL. X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization. Clin Cancer Res. 2004;10:7252–7259.
   PubMed Web of Science ®Google Scholar
• Ryan AM, Power DG, Daly L, et al. Cancer-associated malnutrition, cachexia and sarcopenia: the skeleton in the hospital closet 40 years later Proc Nutr Soc. 2016;75:199–211.
   PubMed Web of Science ®Google Scholar
• Efremova M, Rieder D, Klepsch V, et al. Targeting immune checkpoints potentiates immunoediting and changes the dynamics of tumor evolution. Nat Commun. 2018;9(32).
   Google Scholar
• Zhang Z, Pereira S, Luo M, Matheson E. Evaluation of blood biomarkers associated with risk of malnutrition in older adults: a systematic review and meta-analysis. Nutrients. 2017;9.
   Web of Science ®Google Scholar
• Tobert CM, Hamilton-Reeves JM, Norian LA, et al. Emerging impact of malnutrition on surgical patients: literature review and potential implications for cystectomy in bladder cancer. J Urol. 2017;198:511–519.
   PubMed Web of Science ®Google Scholar
• Königsbrügge O, Posch F, Riedl J, et al. Association between decreased serum albumin with risk of venous thromboembolism and mortality in cancer patients. Oncologist. 2016;21:252–257.
   PubMed Web of Science ®Google Scholar
• Sejima T, Iwamoto H, Toshihiko M, et al. Low pre-operative levels of serum albumin predict lymph node metastases and ultimately correlate with a biochemical recurrence of prostate cancer in radical prostatectomy patients. Central Eur J Urol. 2013;66:126–132.
   PubMedGoogle Scholar
• Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med. 2003;348(17):1625–1638. doi:10.1056/NEJMoa021423
   PubMed Web of Science ®Google Scholar
• Siddiqui SA, Inman BA, Sengupta S, et al. Obesity and survival after radical prostatectomy: a 10-year prospective cohort study. Cancer. 2006;107:521–529.
   PubMed Web of Science ®Google Scholar
• Chalfin HJ, Lee SB, Jeong BC, et al. Obesity and long-term survival after radical prostatectomy. J Urol. 2014;192:1100–1104.
   PubMed Web of Science ®Google Scholar
• Löppenberg B, Dalela D, Karabon P, et al. The impact of local treatment on overall survival in patients with metastatic prostate cancer on diagnosis: a national cancer data base analysis. Eur Urol. 2017;72:14–19.
   PubMed Web of Science ®Google Scholar
• Miura Y, Horie S. The role of hormone therapy and chemotherapy in oligometastatic prostate cancer. ESMO Open. 2019;4:e000471.
   PubMed Web of Science ®Google Scholar
• Predina JD, Kapoor V, Judy BF, et al. Cytoreduction surgery reduces systemic myeloid suppressor cell populations and restores intratumoral immunotherapy effectiveness. J Hematol Oncol. 2012;5:34.
   PubMed Web of Science ®Google Scholar
• Slade AN. Prostate cancer and subsequent nutritional outcomes: the role of diagnosis and treatment. J Cancer Surviv. 2019;13:171–179.
   PubMed Web of Science ®Google Scholar